Promoting Patient-Centeredness in Opioid Deprescribing: a Blueprint for De-implementation Science.

A downward trend in opioid prescribing between 2011 and 2018 has brought per-capita opioid prescriptions below the levels of 2006, the earliest year for which the Centers for Disease Control and Prevention has published data. That trend has affected roughly ten million patients who previously receiv...

Descripción completa

Detalles Bibliográficos
Publicado en:JGIM: Journal of General Internal Medicine Vol. 35; pp. 972 - 978
Autores principales: Kertesz, Stefan G., McCullough, Megan B., Darnall, Beth D., Varley, Allyson L.
Formato: tables/charts Journal Article
Publicado: Springer Nature Nov2020 Supplement 3
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=147528767&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 147528767
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        08848734
        4BF
      jtl: JGIM: Journal of General Internal Medicine
      issn: 08848734
      maglogo: N
    pubinfo:
      dt: Nov2020 Supplement 3
      vid: 35
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        147528767
        146880201
        147528767
        NLM33145692
        147528767
        10.1007/s11606-020-06254-7
        NLM33145692
        147528767
      ppf: 972
      ppct: 6
      formats:
      tig:
        atl: Promoting Patient-Centeredness in Opioid Deprescribing: a Blueprint for De-implementation Science.
      aug:
        au:
          Kertesz, Stefan G.
          McCullough, Megan B.
          Darnall, Beth D.
          Varley, Allyson L.
        affil: Birmingham VA Medical Center, Birmingham, AL, USA
      sug:
        subj:
          Analgesics, Opioid Therapeutic Use
          United States
          Pain Drug Therapy
      ab: A downward trend in opioid prescribing between 2011 and 2018 has brought per-capita opioid prescriptions below the levels of 2006, the earliest year for which the Centers for Disease Control and Prevention has published data. That trend has affected roughly ten million patients who previously received long-term opioid therapy. Any effort to reduce or replace a prior health practice is termed de-implementation. We suggest that the evaluation of opioid prescribing de-implementation has been misdirected, within US policy and health research, resulting in detrimental impacts on patients, their families and clinicians. Policymakers and implementation scientists can address these deficiencies in how we study and how we perform opioid de-implementation by applying an implementation science framework: the Consolidated Framework for Implementation Research. The Consolidated Framework lays out relevant domains of activity (internal, external, etc.) that influence implementation processes and outcomes. It can deepen our understanding of how policies are chosen, communicated, and carried out. Policymakers and researchers who embrace this framework will need a better approach to measuring success and failure in health care where both pain and opioids are concerned. This would involve shifting from a reductive focus on opioid prescription counts toward measures that are more effective, holistic, and patient-centered.
      pubtype: Academic Journal
      doctype:
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N